Company Filing History:
Years Active: 1997
Title: The Innovative Contributions of Michael Zimber
Introduction
Michael Zimber is an accomplished inventor based in Pullman, Washington. He has made significant strides in the field of biotechnology, particularly in the area of pancreatic islet cell research. His work focuses on enhancing the availability of adult pancreatic islet cells for transplantation, which is crucial for diabetes treatment.
Latest Patents
Zimber holds a patent for a method that increases the number of adult pancreatic islet cells available for transplantation. This innovative technique involves contacting the cells with laminin 5 extracellular matrix. Remarkably, when these cells are treated with the deposited matrix produced by 804G rat bladder carcinoma cells, a 1,500-fold increase in cell number is observed after three passages in culture. Additionally, islet cell expansion occurs when cells are exposed to 804G soluble matrix. The expanded islet cells not only contain insulin but also respond effectively to glucose challenges.
Career Highlights
Michael Zimber is associated with Desmos, Inc., where he continues to contribute to advancements in biotechnology. His research has the potential to significantly impact the field of diabetes treatment by improving the availability of transplantable islet cells.
Collaborations
Zimber has worked alongside notable colleagues such as Craig Halberstadt and John J Grzesiak. Their collaborative efforts have furthered research in the field and enhanced the understanding of pancreatic islet cell expansion.
Conclusion
Michael Zimber's innovative work in the field of pancreatic islet cell research exemplifies the importance of advancements in biotechnology. His contributions are paving the way for improved treatments for diabetes, showcasing the vital role of inventors in medical science.